ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Revive Therapeutics Ltd

Revive Therapeutics Ltd (RVV)

0,01
0,00
( 0,00% )
Aktualisiert: 15:30:00

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,01
Gebot
0,005
Fragen
0,01
Volumen
100.000
0,01 Tagesbereich 0,01
0,005 52-Wochen-Bereich 0,04
Handelsende
0,01
Handelsbeginn
0,01
Letzte Trade
10000
@
0.01
Letzter Handelszeitpunkt
15:30:00
Durchschnittliches Volumen (3 Mio.)
409.523
Finanzvolumen
-
VWAP
-

RVV Neueste Nachrichten

Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19

  Revive Therapeutics Announces Publication of Research Data with Bucillamine in COVID-19   TORONTO, Canada -- April 18, 2022 -- InvestorsHub NewsWire -- Revive...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

  Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19   TORONTO, Canada -- April 12, 2022 -- InvestorsHub NewsWire -- Revive...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19   Expected to seek DSMB approval to proceed with EUA application to the FDA in...

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19Ethics Committee approval to proceed with Phase 3 clinical trial in Turkey13 clinical sites selected to...

Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs

 Revive Therapeutics Provides Update of Psilocybin Pharmaceutical Programs IRB approval to initiate Phase 2 study for methamphetamine abuse disorders Advancing psilocybin oral thin film...

Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19

 Revive Therapeutics Clarifies Status of Its Phase 3 Clinical Trial for Bucillamine in COVID-19 Approximately 700 subjects participated in the enrollment periodExpected to begin subject enrollment...

Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer

  Revive Therapeutics Signs Exclusive Worldwide License Agreement For Medicinal Mushroom Ganoderma Lucidum To Treat Cancer Novel discovery and research originated from Universidad Central del...

Revive Confirms No Material Undisclosed Information

  Revive Confirms No Material Undisclosed Information   Toronto, Ontario, Canada -- August 12, 2021 -- InvestorsHub NewsWire -- Revive Therapeutics Ltd...

Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline

Revive Therapeutics Provides Update on Psychedelics Clinical Product Pipeline   Focusing on novel uses, production and delivery forms of psilocybin as a next generation solution...

Revive Therapeutics Approved to Trade on the OTCQB Market

 Revive Therapeutics Approved to Trade on the OTCQB Market TORONTO, June 25, 2021 -- InvestorsHub NewsWire -- Revive Therapeutics Ltd. ("Revive" or the "Company") (CSE: RVV, USA: RVVTF, FRANKFURT:...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.010.010.0052979760.01CS
4000.010.010.0053340980.00842445CS
12000.010.020.0054095230.0119481CS
26-0.025-71.42857142860.0350.0350.0054037120.01342685CS
52-0.02-66.66666666670.030.040.0052966790.01901764CS
156-0.465-97.89473684210.4750.60.0053507780.17154059CS
260-0.05-83.33333333330.060.920.0058717500.31361174CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
CATCAT Strategic Metals Corporation
$ 0,01
(100,00%)
1.000
SPFYSpacefy Inc
$ 0,01
(100,00%)
40k
VTALJustera Health Ltd
$ 0,01
(100,00%)
56,85k
MEATModern Plant Based Foods Inc
$ 0,33
(83,33%)
4k
URMFirst American Uranium Inc
$ 0,025
(66,67%)
53k
LAI.XLa Imperial Resources Inc
$ 0,005
(-83,33%)
10k
FREEFree Battery Metal Limited
$ 0,005
(-50,00%)
703k
NLRNorthern Lights Resources Corp
$ 0,005
(-50,00%)
6k
WRUNWaverunner Capital Inc
$ 0,01
(-50,00%)
34k
MYCOMydecine Innovations Group Inc
$ 0,005
(-50,00%)
4k
HMLHeritage Mining Ltd
$ 0,055
(10,00%)
2,05M
SPIRSpirit Blockchain Capital Inc
$ 0,05
(42,86%)
1,95M
QIMCQuebec Innovative Materials Corp
$ 0,375
(7,14%)
1,64M
HODLSol Strategies Inc
$ 0,32
(6,67%)
1,23M
LEEFLeef Brands Inc
$ 0,025
(0,00%)
1,12M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock